Adenosine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Adenosine and local guidelines before prescribing.
Mechanism
Activates A1 receptors, causing transient AV nodal block and interrupting re-entrant tachycardia.
Uses
Regular narrow-complex (AV re-entrant) SVT; diagnostic aid in flutter or broad-complex tachycardia.
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Regular narrow-complex SVT | 6 mg rapid IV → 12 mg → 18 mg | Avoid in irregular wide-complex tachycardia; flush immediately. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
This drug is not covered by a dedicated section of the textbook chapters.
Side effects
Flushing, chest tightness, dyspnoea, transient asystole or bradycardia, sense of doom.
Interactions
Dipyridamole and theophylline interact (potentiate or antagonise); carbamazepine prolongs block.
Contraindications and cautions
Asthma or severe COPD, 2nd/3rd-degree heart block, sick sinus syndrome, long QT
Monitoring
Continuous ECG during use
Pregnancy and breastfeeding
Use where indicated
Renal and hepatic impairment
No adjustment
Overdose and reversal
Effects last seconds; aminophylline reverses
Special advice
Give by rapid bolus with a fast flush, with ECG recording; avoid in asthma, high-grade block and pre-excited AF; warn the patient of brief unpleasant symptoms.